Table 2 Analysis of T cell subsets, IgM, Transferrin, NLR, CRP and D-Dimer in stage III–IV NSCLC Patients
Characteristics | R (n = 65) | NR (n = 39) | p value |
|---|---|---|---|
CD3+ (%) | 71.09 ± 9.34 | 67.23 ± 10.76 | 0.149 |
CD4+ (%) | 41.48 ± 10.38 | 38.04 ± 11.16 | 0.226 |
CD8+ (%) | 23.70 (20.02, 28.50) | 24.25 (17.23, 33.25) | 0.971 |
CD4/CD8 | 1.76 (1.26, 2.29) | 1.91 (0.91, 2.08) | 0.594 |
CD16 + 56+ (%) | 14.80 (9.43, 18.95) | 17.50 (11.00, 24.70) | 0.122 |
CD19+ (%) | 7.60 (3.93, 12.20) | 8.35 (6.00, 11.01) | 0.343 |
IgM (g/L) | 0.84 (0.72, 1.11) | 0.89 (0.67, 1.12) | 0.931 |
IgG (g/L) | 11.85 (9.33, 13.30) | 12.60 (11.15, 15.10) | 0.167 |
IgA (g/L) | 2.42 (1.92, 2.77) | 2.31 (1.98, 3.04) | 0.853 |
IgE (g/L) | 75.00 (26.20, 157.00) | 41.00 (18.45, 76.80) | 0.088 |
IgM (g/L) | 0.84 (0.72, 1.11) | 0.89 (0.67, 1.12) | 0.931 |
Fibrinogen | 4.06 ± 1.27 | 4.83 ± 1.40 | 0.009 |
Eosinophil | 0.14 (0.06, 0.25) | 0.11 (0.04, 0.21) | 0.180 |
NLR | 3.13 (2.36, 5.93) | 4.34 (3.53, 8.94) | 0.002 |
D-Dimer (mg/L) | 1.01 (0.56, 1.85) | 2.10 (1.13, 3.46) | 0.007 |
Albumin | 37.04 ± 5.27 | 32.21 ± 4.86 | 0.000 |
LDH | 224.50 (191.15, 300) | 330.45 (262, 507.50) | 0.001 |